The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study

被引：0

作者：

Chiappella, Annalisa ^{[1
]}

Dodero, Anna ^{[2
]}

Evangelista, Andrea ^{[3
]}

Re, Alessandro ^{[4
]}

Orsucci, Lorella ^{[5
]}

Usai, Sara Veronica ^{[6
]}

Castellino, Claudia ^{[7
]}

Stefoni, Vittorio ^{[8
]}

Pinto, Antonio ^{[9
]}

Zanni, Manuela ^{[10
]}

Ciancia, Rosanna ^{[11
]}

Ghiggi, Chiara ^{[12
]}

Rossi, Francesca Gaia ^{[13
]}

Arcari, Annalisa ^{[14
]}

Ilariucci, Fiorella ^{[15
]}

Zilioli, Vittorio Ruggero ^{[16
]}

Flenghi, Leonardo ^{[17
]}

Celli, Melania ^{[18
]}

Volpetti, Stefano ^{[19
]}

Benedetti, Fabio ^{[20
]}

Ballerini, Filippo ^{[21
]}

Musuraca, Gerardo ^{[22
]}

Bruna, Riccardo ^{[23
]}

Patti, Caterina ^{[24
]}

Leonardi, Francesco ^{[25
]}

Arcaini, Luca ^{[26
,27
]}

Magagnoli, Massimo ^{[28
]}

Cavallo, Federica ^{[29
]}

Tabanelli, Valentina ^{[30
]}

Ciccone, Giovannino ^{[31
]}

Pileri, Stefano A. ^{[32
]}

Corradini, Paolo ^{[33
]}

机构：

[1] Fdn IRCCS Ist Nazl Tumori, Div Hematol & Stem Cell Transplant, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Hematol, Milan, Italy

[3] Unit Clin Epidemiol Citta Salute & Sci Torino, Turin, Italy

[4] ASST Spedali Civili, Dept Hematol, Brescia, Italy

[5] Citte Salute Hosp & Univ, Hematol, Turin, Italy

[6] Osped Oncol Armando Businco, Hematol, Cagliari, Italy

[7] Azienda Osped S Croce & Carle, Div Hematol, Cuneo, Italy

[8] Univ Bologna, Dept Translat & Precis Med, Hematol, Bologna, Italy

[9] Fdn G Pascale, Natl Canc Inst, Dept Hematol & Innovat Therapies, Hematol Oncol & Stem Cell Transplantat Unit,IRCCS, Naples, Italy

[10] Azienda Osped Santi Antonio & Biagio & Cesare Arr, Div Hematol, Alessandria, Italy

[11] Ctr Riferimento Oncol CRO IRCCS, Oncohematol & Stem Cell Transplantat & Cellular T, Aviano, Italy

[12] IRCCS Osped Policlin San Martino, Hematol, Genoa, Italy

[13] Fdn IRCCS Ca Granda, Div Hematol, OM Policlin, Milan, Italy

[14] Osped Guglielmo Saliceto, Hematol Unit, Piacenza, Italy

[15] Azienda Ausl IRCCS Santa Maria Nuova Reggio Emili, Reggio Emilia, Italy

[16] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy

[17] Osped S Maria Misericordia, Hematol, Perugia, Italy

[18] Osped Infermi Rimini, UO Ematol, Rimini, Italy

[19] Presidio Osped Univ Santa Maria Misericordia Udin, ASUFC, Clin Hematol, Udine, Italy

[20] Azienda Osped Univ Verona, Hematol & Stem Cell Transplantat, Verona, Italy

[21] IRCCS Osped Policlin San Martino, Clin Hematol, Dept Internal Med DiMI, Genoa, Italy

[22] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Div Hematol, Meldola, Italy

[23] Osped Maggiore La Carita, Div Hematol, Novara, Italy

[24] Azienda Villa Sofia Cervello, Div Onco Hematol, Palermo, Italy

[25] Azienda Osped Univ Parma, Hematol & CTMO, Parma, Italy

[26] Fdn IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy

[27] Univ Pavia, Dept Mol Med, Pavia, Italy

[28] IRCCS Humanitas Res Hosp, Hematol, Rozzano Milano, Italy

[29] AOU Citta Salute & Sci Torino, Div Hematol, Turin, Italy

[30] IEO Ist Europeo Oncol IRCCS, Div Diagnost Haematopathol, Milan, Italy

[31] AOU Citta Salute & Sci Torino, Unit Canc Epidemiol, CPO Piemonte, Turin, Italy

[32] IEO Ist Europeo Oncol IRCCS, Hematopathol Div, Milan, Italy

[33] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Milan, Italy

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-163824

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6538 / 6539

页数：2

共 46 条

[31] Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study
Elizabeth H. Phillips
Michelle M. Lannon
Andre Lopes
Humra Chadwick
Gail Jones
Michal Sieniawski
Andrew Davies
Katrina Wood
Laura Clifton-Hadley
Paul Smith
Anthony Lawrie
Nick Chadwick
Anne L. Lennard
Bone Marrow Transplantation, 2020, 55 : 840 - 840
[32] Preliminary results of a Nordic phase II study on dose-intensive induction and high-dose therapy (HDT) with autologous stem cell rescue (ASCR) as primary treatment for peripheral T-cell lymphomas (PTCL).
d'Amore, F
Holte, H
Cavallin-Ståhl, E
Enblad, G
Jantunen, E
Ralfkiaer, E
Anderson, H
Lauritzsen, G
Hansen, M
Telhaug, R
Delabie, J
Sundström, C
BLOOD, 2003, 102 (11) : 292B - 292B
[33] Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Vitolo, Umberto
Chiappella, Annalisa
Angelucci, Emanuele
Rossi, Giuseppe
Liberati, Anna Marina
Cabras, Maria Giuseppina
Botto, Barbara
Ciccone, Giovannino
Gaidano, Gianluca
Falchi, Lorenzo
Freilone, Roberto
Novero, Domenico
Orsucci, Lorella
Pavone, Vincenzo
Pogliani, Enrico
Rota-Scalabrini, Delia
Salvi, Flavia
Tonso, Anna
Tucci, Alessandra
Levis, Alessandro
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09): : 1250 - 1258
[34] Reduced-intensity conditioning followed by allogeneic transplantation has a better outcome than high-dose chemotherapy plus autografting in T-cell non-Hodgkin's lymphoma
Corradini, P
Dodero, A
Zallio, F
Dinicola, M
Caracciolo, D
Ciceri, F
Cuttica, A
Boccadoro, M
Gianni, A
Pileri, A
Tarella, C
BONE MARROW TRANSPLANTATION, 2003, 31 : S67 - S67
[35] Long term remission in follicular lymphoma (FL) and mantle cell lymphoma (MCL) with rituximab consolidation after high-dose chemotherapy and autologous stem cell transplantation: Extended follow-up of a multicenter phase II study.
Brugger, W
Hirsch, J
Repp, R
Frank, G
Guenther, S
Wichard, V
Markus, M
Peter, B
Kaufmann, M
Ganser, A
Fehnle, K
Gramatzki, M
Kanz, L
BLOOD, 2005, 106 (11) : 588A - 588A
[36] Graft-versus-lymphoma effect in peripheral T-cell lymphomas (PTCL): Reduced-intensity conditioning followed by allogeneic transplantation gives a better outcome than high-dose chemotherapy followed by autografting.
Corradini, P
Dodero, A
Zallio, F
Cuttica, A
Caracciolo, D
Di Nicola, M
Casini, M
Ciceri, F
Narni, F
Patriarca, F
Boccadoro, M
Gianni, AM
Tarella, C
BLOOD, 2003, 102 (11) : 900A - 901A
[37] High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (vol 54, pg 465, 2019)
Phillips, Elizabeth H.
Lannon, Michelle M.
Lopes, Andre
Chadwick, Humra
Jones, Gail
Sieniawski, Michal
Davies, Andrew
Wood, Katrina
Clifton-Hadley, Laura
Smith, Paul
Lawrie, Anthony
Chadwick, Nick
Lennard, Anne L.
BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 840 - 840
[38] B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
Balzarotti, Monica
Brusamolino, Ercole
Angelucci, Emanuele
Carella, Angelo Michele
Vitolo, Umberto
Russo, Eleonora
Congiu, Angelagiovanna
Gotti, Manuel
Massidda, Stefania
Botto, Barbara
Annechini, Giorgia
Spina, Michele
Re, Alessandro
Zilioli, Vittorio Ruggero
Merli, Francesco
Salvi, Flavia
Stelitano, Caterina
Bonfichi, Maurizio
Rodari, Marcello
Murru, Roberta
Magagnoli, Massimo
Anastasia, Antonella
Mazza, Rita
Giordano, Laura
Santoro, Armando
LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2375 - 2381
[39] High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II Study
Ruan, Jia
Moskowitz, Alison J.
Mehta-Shah, Neha
Sokol, Lubomir
Chen, Zhengming
Rahim, Riyaad
Song, Wei
Kotlov, Nikita
Nos, Grigorii
Maksimov, Vladislav
Revuelta, Maria Victoria
Sboner, Andrea
Sigouros, Michael
Besien, Koenvan
Horwitz, Steven M.
Rutherford, Sarah C.
Mulvey, Erin C.
Coleman, Morton
Melnick, Ari
Elemento, Olivier
Inghirami, Giorgio
Leonard, John P.
Martin, Peter
Cerchietti, Leandro
BLOOD, 2021, 138
[40] Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04)
Tohru Murayama
Takahiro Fukuda
Hirokazu Okumura
Kazutaka Sunami
Aiko Sawazaki
Yoshinobu Maeda
Hisashi Tsurumi
Naokuni Uike
Tomonori Hidaka
Yoshifusa Takatsuka
Tetsuya Eto
Hiroyuki Tsuda
Tomoaki Fujisaki
Toshihiro Miyamoto
Naoko Tsuneyoshi
Satoshi Iyama
Koji Nagafuji
Mine Harada
International Journal of Hematology, 2016, 103 : 676 - 685

← 1 2 3 4 5 →